Rationale: Multidrug-resistant organisms (MDRO) are the dominant airway pathogens in the
intensive care unit (ICU) and present a major treatment challenge to intensivists …

Ventilator-associated pneumonia (VAP) is the leading cause of death related to infection in
critically ill patients and accounts for more than 50% of the antibiotic use in the intensive …

Aerosolized antibiotics in mechanically ventilated patients:... : Critical Care Medicine
Aerosolized antibiotics in mechanically ventilated patients: Delivery and response : Critical Care …

Objective: The purpose of this study was to determine whether aerosolized antibiotics, which
achieve high drug concentrations in the target organ, would more effectively treat respiratory …

Aerosolized antibiotics in critically ill ventilated patient... : Current Opinion in Critical Care
Aerosolized antibiotics in critically ill ventilated patients : Current Opinion in Critical Care Log …

Aerosolized Antibiotics: Current and Future Page 1 Aerosolized Antibiotics: Current and Future
Gerald C Smaldone MD PhD and Lucy B Palmer MD Introduction Ambulatory Patients–Cystic …

Aerosolized antibiotics to treat ventilator-associated pneum... : Current Opinion in Infectious
Diseases Aerosolized antibiotics to treat ventilator-associated pneumonia : Current Opinion in …

Background Ventilator-associated pneumonia is the leading nosocomial infection in critically
ill patients. The frequency of ventilator-associated pneumonia caused by multidrug-resistant …

The emergence of multiple-drug resistant pathogens in patients who are seriously ill
represents a new challenge for the critical care physician. In the therapy of pneumonia and …

Antibiotics represent one of the most commonly prescribed medical therapies for
hospitalized patients. The practice of" spiralling empiricism" has increasingly led to the …